Stemline Therapeutics Inc (NASDAQ:STML)

16.31
Delayed Data
As of 11:07am ET
 -0.0101 / -0.06%
Today’s Change
10.50
Today|||52-Week Range
18.94
-4.40%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Hoberman Kenneth
Chief Operating Officer
Sale3/19/201517,307$16.43$284.4K+0.87%
Hoberman Kenneth
Chief Operating Officer
Sale5/21/201415,250$13.32$203.1K+22.89%
Bergstein Ivan
Chief Executive Officer
Sale11/26/201411,974$14.40$172.4K+10.34%
Rowinsky Eric K
Chief Medical Officer
Sale4/25/201410,879$15.01$163.3K+9.90%
Hoberman Kenneth
Chief Operating Officer
Buy3/19/201527,105$4.09$110.9K+0.87%
Gionco David G
Chief Accounting Officer
Sale1/20/20153,311$14.22$47.1K+14.37%
Bergstein Ivan
Chief Executive Officer
Sale2/18/20153,180$14.02$44.6K+15.91%
Rowinsky Eric K
Chief Medical Officer
Sale2/18/20151,640$13.99$22.9K+15.91%
Bentsur Ronald
Director
Sale3/18/20151,388$16.12$22.4K+2.45%
Hoberman Kenneth
Chief Operating Officer
Sale2/18/20151,593$14.02$22.3K+15.91%
Page of 2

To view my watchlist

Not a member yet?

Sign up now for a free account